(0.29%) 5 114.76 points
(0.30%) 38 356 points
(0.31%) 15 977 points
(-0.92%) $83.08
(5.77%) $2.03
(0.37%) $2 355.80
(0.44%) $27.66
(4.00%) $959.00
(-0.22%) $0.933
(-0.38%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
@ $5.47
発行日: 15 2月 2024 @ 04:51
リターン: -29.62%
前回のシグナル: 2月 15 - 02:36
前回のシグナル:
リターン: 1.86 %
Live Chart Being Loaded With Signals
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa...
Stats | |
---|---|
本日の出来高 | 19 624.00 |
平均出来高 | 180 475 |
時価総額 | 190.11M |
EPS | $0 ( 2024-03-04 ) |
次の収益日 | ( $-0.300 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.69 |
ATR14 | $0.00800 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Ek John Frederick | Sell | 14 272 | Common Stock |
2024-03-23 | Pla Frederic | Sell | 2 006 | Common Stock |
2024-03-23 | Ramachandran Niro Ph.d | Sell | 2 006 | Common Stock |
2024-03-23 | Mckelligon Brian | Sell | 7 135 | Common Stock |
2024-03-20 | Mckelligon Brian | Sell | 7 500 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
67.46 |
Last 99 transactions |
Buy: 5 199 597 | Sell: 937 556 |
ボリューム 相関
Akoya Biosciences, Inc. 相関
10 最も負の相関 | |
---|---|
OHAA | -0.95 |
BRIVU | -0.942 |
NVCN | -0.942 |
PRDO | -0.94 |
PPYAU | -0.939 |
MSDA | -0.939 |
HDSN | -0.932 |
SENEA | -0.93 |
TIOA | -0.928 |
XFIN | -0.928 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Akoya Biosciences, Inc. 相関 - 通貨/商品
Akoya Biosciences, Inc. 財務諸表
Annual | 2023 |
収益: | $96.63M |
総利益: | $48.24M (49.92 %) |
EPS: | $-1.430 |
FY | 2023 |
収益: | $96.63M |
総利益: | $48.24M (49.92 %) |
EPS: | $-1.430 |
FY | 2022 |
収益: | $74.86M |
総利益: | $43.39M (57.96 %) |
EPS: | $-1.870 |
FY | 2021 |
収益: | $54.92M |
総利益: | $13.52M (24.62 %) |
EPS: | $-1.485 |
Financial Reports:
No articles found.
Akoya Biosciences, Inc.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。